- Feb 5, 2002
- 179,007
- 64,245
- Country
- United States
- Gender
- Female
- Faith
- Catholic
- Marital Status
- Married
- Politics
- US-Others
A first-of-its-kind study by the Ethics and Public Policy Center that delves into public-health insurance records found that more than 1 in 10 women who take mifepristone to complete a chemical abortion will suffer a serious health complication during the process.
A first-of-its-kind study that delves into public-health insurance records found that more than 1 in 10 women who take the abortion pill mifepristone to complete a chemical abortion will suffer a serious health complication during the process.
The study of 865,727 patients between 2017 and 2023, which was published by the Ethics and Public Policy Center (EPPC) on April 28, discovered that 10.93% of women suffer at least one “serious adverse event” within 45 days of taking mifepristone for an abortion.
“This isn’t idle speculation; this is based on the largest data set that we know of,” Ryan Anderson, the president of EPPC and one of the study’s authors, told EWTN.
More than 4.7% were forced to visit an emergency room related to the abortion, more than 3.3% suffered hemorrhaging, and more than 1.3% got an infection. Thousands were hospitalized, more than 1,000 needed blood transfusions, and hundreds suffered from sepsis. Nearly 2,000 had a different life-threatening adverse event.
Continued below.
www.ncregister.com
A first-of-its-kind study that delves into public-health insurance records found that more than 1 in 10 women who take the abortion pill mifepristone to complete a chemical abortion will suffer a serious health complication during the process.
The study of 865,727 patients between 2017 and 2023, which was published by the Ethics and Public Policy Center (EPPC) on April 28, discovered that 10.93% of women suffer at least one “serious adverse event” within 45 days of taking mifepristone for an abortion.
“This isn’t idle speculation; this is based on the largest data set that we know of,” Ryan Anderson, the president of EPPC and one of the study’s authors, told EWTN.
More than 4.7% were forced to visit an emergency room related to the abortion, more than 3.3% suffered hemorrhaging, and more than 1.3% got an infection. Thousands were hospitalized, more than 1,000 needed blood transfusions, and hundreds suffered from sepsis. Nearly 2,000 had a different life-threatening adverse event.
Continued below.
Study of Over 865,000 Abortion-Pill Patients: 11% Suffer ‘Serious Adverse Events’
A first-of-its-kind study by the Ethics and Public Policy Center that delves into public-health insurance records found that more than 1 in 10 women who take mifepristone to complete a chemical abortion will suffer a serious health complication during the process.
